This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, M.
Right arrow Articles by Wang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, M.
Right arrow Articles by Wang, H.

 Previous Article  |  Next Article 

Journal of Virology, October 2008, p. 9800-9804, Vol. 82, No. 19
0022-538X/08/$08.00+0     doi:10.1128/JVI.00759-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The F-Like Protein Ac23 Enhances the Infectivity of the Budded Virus of gp64-Null Autographa californica Multinucleocapsid Nucleopolyhedrovirus Pseudotyped with Baculovirus Envelope Fusion Protein F{triangledown} ,{dagger}

Manli Wang,1,3,{ddagger} Ying Tan,1,3,{ddagger} Feifei Yin,1,3 Fei Deng,1 Just M. Vlak,2 Zhihong Hu,1 and Hualin Wang1*

State Key Laboratory of Virology and Joint Laboratory of Invertebrate Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, People's Republic of China,1 Laboratory of Virology, Wageningen University, 6709 PD Wageningen, The Netherlands,2 Graduate School of the Chinese Academy of Sciences, Beijing 100039, People's Republic of China3

Received 7 April 2008/ Accepted 16 July 2008


arrow
ABSTRACT
 
The GP64 and F proteins were previously identified as the sole functional envelope fusion proteins in Baculoviridae. F-like proteins, present only in group I nucleopolyhedroviruses (NPVs), are remnant, nonfunctional F proteins. In this report, we describe the effect of the presence or absence of the F-like protein Ac23 in a gp64-null Autographa californica multinucleocapsid NPV pseudotyped with the F protein from Spodoptera exigua multicapsid NPV (SeF). We found that the presence of Ac23 elevates the infectivity of the pseudotyped virus. This is in contrast to the results of Lung et al. (J. Virol. 76:5729-5736, 2002), who found no such effect. The possible reasons for the differing results are discussed.


arrow
TEXT
 
The entry of enveloped viruses into host cells is usually mediated by one or more of their envelope proteins. Two types of envelope fusion proteins, GP64 and F, were identified in budded viruses (BV) of group I and group II nucleopolyhedroviruses (NPVs), respectively (3, 9, 14). These proteins are responsible for virus binding to cell receptors, for mediating the fusion of viral and endosomal membranes, and for efficient budding and egress (1, 2, 5, 6, 11). They are considered to be the only functional membrane fusion proteins within the Baculoviridae family.

Apart from GP64, group I NPVs also contain F-like proteins, such as those encoded by Ac23 from Autographa californica multinucleocapsid NPV (AcMNPV) (7) and Op21 from Orgyia pseudotsugata MNPV (10). These F-like proteins coexist with GP64 on the surface of BVs (10) and are thought to be remnants of a functional F. The F-like proteins are structurally different from F proteins in that the former lack a furin cleavage site and thus cannot function as fusion proteins (10). Lung et al. (7) have shown that Ac23 is not essential for AcMNPV infection, propagation, and BV production in cell culture but that it is a viral pathogenicity factor. Insects infected with AcMNPV lacking Ac23 kill infected insect larvae in a longer time (7). However, since the F-like proteins are present in BVs, we hypothesize that the proteins may have function at the cellular level. Therefore, in the current study, the function of Ac23 was investigated in the absence of GP64 but in the presence of a functional but less-fusogenic F protein from group II NPVs (SeF). We observed that a deletion mutant of AcMNPV lacking both GP64 and Ac23 but containing SeF (vAcgp64– Ac23–-SeF) produced significantly fewer infectious BVs than wild-type AcMNPV. This system appeared suitable to investigate possible auxiliary functions of Ac23 in BV infection.

To investigate the function of Ac23 in the absence of GP64, recombinant AcMNPV bacmids were generated (Fig. 1), namely, the "wild type" control bAc-egfp, with egfp transposed into the polyhedrin locus; AcMNPV lacking gp64 (bAcgp64–) and AcMNPV lacking both gp64 and Ac23 (bAcgp64– Ac23–); both mutants carrying SeF (bAcgp64–-SeF and bAcgp64– Ac23–-SeF), with an egfp and a cat cassette in the gp64 locus; and a control bacmid, an AcMNPV rescue bacmid with gp64 and Ac23 reinserted into AcMNPV (bAcgp64– Ac23–-gp64-Ac23). Details of the construction and verification of the bacmids are in the supplemental material. Recombinant bacmids were transfected into Sf9 cells, and 4 days posttransfection (p.t.), green fluorescence was detected in the cells, indicating successful transfection (Fig. 2A, panels a, b, c, d, e, and f). At 6 days p.t., a supernatant sample was used to infect another batch of Sf9 cells, which were inspected 4 days postinfection (p.i.) for enhanced green fluorescent protein (EGFP) fluorescence.


Figure 1
View larger version (28K):
[in this window]
[in a new window]

  		FIG. 1. Genomic structure of recombinant bacmids bAc-egfp, bAcgp64–, bAcgp64–-SeF, bAcgp64– Ac23–, bAcgp64– Ac23–-SeF, bAcgp64– Ac23–-gp64-Ac23 and parental bacmid AcMNPV (bMON14272). Dash-and-dot lines represent the substitution of the corresponding cassettes.


Figure 2
Figure 2
View larger version (83K):
[in this window]
[in a new window]

  		FIG. 2. Transfection and infection assays of AcMNPV recombinants for viral propagation. (A) Sf9 cells were transfected with bacmids bAc-egfp (a), bAcgp64– (b), bAcgp64–-SeF (c), bAcgp64– Ac23– (d), bAcgp64– Ac23–-SeF (e), and bAcgp64– Ac23–-gp64-Ac23 (f). One microgram of DNA of each recombinant bacmid was transfected into 1 x 106 Sf9 cells in a 35-mm-diameter tissue culture dish by using 12 µl Lipofectin reagent according to the Bac-to-Bac expression system manual (Invitrogen). Six days p.t., supernatants from the transfected cells (panels a, b, c, d, e, and f) were used to infect healthy Sf9 cells (panels a', b', c', d', e', and f'). Levels of infection were recorded by fluorescence at 4 days p.t. or p.i. (B) Results of one-step BV growth curve analyses of vAc-egfp, vAcgp64–-SeF, vAcgp64– Ac23–-SeF, and vAcgp64– Ac23–-gp64-Ac23. Sf9 cells were infected at a multiplicity of infection of 5 TCID50 U per cell for each virus in triplicate. Titers of progeny viruses at various time points p.i. were determined by performing an end-point dilution assay (4). Data points represent the mean titers of the triplicate infections, and error bars represent the standard deviations from the means. BV titers were logarithmically transformed and analyzed by using two-way analysis of variance (SPSS, Inc., 2003) with virus type and time as factors.

Bacmids bAcgp64– (Fig. 2A, panel b') and bAcgp64– Ac23– (Fig. 2A, panel d') did not produce infectious BVs because of the absence of the gp64 gene, which is essential for viral entry and budding, as reported by previous studies (1, 2, 8). However, with the control bacmid bAc-egfp (Fig. 2A, panel a') and the full-rescue bacmid bAcgp64– Ac23–-gp64-Ac23 (Fig. 2A, panel f'), the transfected cells produced BVs which were able to infect healthy cells. The F-repaired bacmids bAcgp64–-SeF (Fig. 2A, panel c') and bAcgp64– Ac23–-SeF (Fig. 2A, panel e') were able to produce BVs and generate systemic infections in the Sf9 cell culture that were comparable to those of control bacmid-derived BVs (Fig. 2B). These results are consistent with a previous conclusion that F proteins are functionally analogous to GP64 (6) and that Ac23 is not essential for BV production in the presence of GP64 (7). We now demonstrate that Ac23 is also not essential for BV production when AcMNPV is pseudotyped with a functional heterologous F protein.

To see to what extent Ac23 contributes to the production of infectious BVs, one-step growth curves of vAc-egfp, vAcgp64–-SeF, vAcgp64– Ac23–-SeF, and vAcgp64– Ac23–-gp64-Ac23 were made and compared (Fig. 2B). Sf9 cells were infected with the respective viruses, and the supernatants sampled at different time points after infection and tested in an end point dilution assay (4). The BV production curves were very similar for vAcgp64– Ac23–-gp64-Ac23 and vAc-egfp (F [Fisher's statistic] = 77.604; df [degree of freedom] = 1 and 52; P = 0.703), indicating that the reinsertion of gp64 and Ac23 into AcMNPV not only rescued infectivity but also rescued the BV yields to wild-type levels. However, in the late phase of infection vAcgp64– Ac23–-SeF produced approximately 100-fold fewer infectious progeny BV than vAcgp64–-SeF (Fig. 2B) and showed a lower titer of virus (1.04 x 105 50% tissue culture infective dose [TCID50] U/ml) than its control virus, vAcgp64–-SeF (8.31 x 106 TCID50 U/ml). Thus, vAcgp64– Ac23–-SeF produced significantly fewer BVs over time than other pseudotyped viruses (F = 77.604; df = 3 and 52; P < 0.01). In our study, vAcgp64–-SeF exhibited replication kinetics and levels of virus production similar to those of control viruses vAcgp64– Ac23–-gp64-Ac23 and vAc-egfp (F = 77.604; df = 2 and 52; P = 0.066) (Fig. 2B). This is in contrast to what has been reported previously (6), where SeF-pseudotyped AcMNPV never reached wild-type levels. This may be due to differences in the promoters driving SeF expression or in the reporter genes that were used and their locations (see below).

To confirm the correct deletion of gp64 and Ac23 and the expression and incorporation of the SeF gene in AcMNPV, Western blot analyses were performed on purified BVs (Fig. 3). GP64 was detected in vAcgp64– Ac23–-gp64-Ac23 (lane A3) and vAc-egfp (lane A4) as 64-kDa bands, but not in vAcgp64– Ac23–-SeF (lane A1) and vAcgp64–-SeF (lane A2). Bands corresponding to Ac23 (approximately 80 kDa) were detected in vAcgp64–-SeF (lane B2), vAcgp64– Ac23–-gp64-Ac23 (lane B3), and vAc-egfp (lane B4), as expected, but not in vAcgp64– Ac23–-SeF (lane B1). The results of these analyses confirmed the expected AcMNPV gp64-null and Ac23-null protein phenotypes and demonstrated the successful incorporation of both gp64 and Ac23 into BVs of the rescued viruses and the incorporation of Ac23 into the gp64-null AcMNPV pseudotyped with SeF. A band corresponding to a protein with a molecular mass identical to the predicted molecular mass of the cleaved F1 fragment of SeF (60 kDa) (13) was detected in vAcgp64– Ac23–-SeF (lane C1) and vAcgp64–-SeF (lane C2), indicating that the majority of SeF was correctly cleaved by furin into F1 and F2 subunits and incorporated into the BVs. A minor band of uncleaved F proprotein SeF0 (80 kDa) was also present, as shown previously in SeF-pseudotyped Helicoverpa armigera NPV (12). The antinucleocapsid antibody of VP39 (approximately 39 kDa) (15) was used as an internal control for the presence of equal amounts of BV extracts in the respective lanes (Fig. 3D).


Figure 3
View larger version (25K):
[in this window]
[in a new window]

  		FIG. 3. Results of Western blot analyses of proteins corresponding to the respective viruses. Lanes for all panels are as follows: 1, vAcgp64– Ac23–-SeF; 2, vAcgp64–-SeF; 3, vAcgp64– Ac23–-gp64-Ac23; and 4, vAc-egfp. Lane M contains the protein markers, with molecular masses indicated on the left. BVs were harvested and purified from the supernatants of infected Sf9 cells at 3 days p.i., and the proteins were separated by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The blots were probed with antibodies as shown above the panels. The anti-GP64 antibody used was monoclonal antibody AcV5 at a 1:1,000 dilution.

To investigate whether the reduced infectivity of vAcgp64– Ac23–-SeF was due to lower BV yield or lower infectivity, quantitative real-time PCR was performed on the various recombinant viruses, using primers for the amplification of a 340-bp region of the lef-8 gene (GeneID no. 1403882) (the methodology is described in the supplemental material). The quantitative PCR results show that for vAcgp64– Ac23–-SeF, one TCID50 unit tested by end point dilution assay was equivalent to 105 copies of viral genome DNA (Table 1). For the control viruses, vAcgp64– Ac23–-SeF, vAcgp64– Ac23–-gp64-Ac23, and vAc-egfp, one TCID50 unit was equivalent to 104 copies of viral genome DNA (Table 1). Therefore, vAcgp64– Ac23–-SeF was about 10 times less infectious than the control viruses (F = 33.731; df = 3 and 11; P < 0.01). However, according to the end point dilution assay results, the level of infectious-BV production of vAcgp64– Ac23–-SeF was about 100 times lower than the levels for the control viruses, indicating that the BV yield was also reduced.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Quantitative PCR for determining viral genome DNA copies compared to viral titers

Taken together, our results indicate that the presence of Ac23 contributes to both the yield and the infectivity of BVs in cell culture. This result is consistent with and provides an explanation for previous findings that Ac23 is a pathogenicity factor in vivo and that the infection of insects by AcMNPV is severely delayed when Ac23 is not present (7). Our findings on the contribution of Ac23 to the infectivity of BVs also suggest that the product of Ac23 contributes to the binding process and may be an accessory protein, which is consistent with indirect evidence obtained by Zhou and Blissard (16). Although our construct required the presence of Ac23 to achieve full levels of infectivity, a construct described by Lung et al. (6) was defective even when Ac23 was present. The major differences between our construct and the one described in reference 6 are the type and location of the reporter genes used (EGFP-polyhedrin locus and GUS-gp64 locus, respectively). In addition, SeF was expressed from both the gp64 and the polyhedrin promoter in our construct but only from the gp64 promoter in the construct of Lung et al. (6). Therefore, the levels of SeF expressed from our construct may have been higher than in the construct of Lung et al. (6). However, the precise role that these different types of reporters and their location and the promoters used to drive SeF play in the differing properties of these two constructs remains to be determined.

In summary, the results of our study provide strong support for the view that the F-like protein Ac23 is a virulence factor not only in vivo but also in vitro. The F-pseudotyped gp64-null AcMNPVs used in the current study are considered to be a useful platform for studying further the function of F-like proteins in baculovirus infection both in vitro and in vivo.


arrow
ACKNOWLEDGMENTS
 
This work was supported by grants from the National Natural Science Foundation of China (30470076, 30630002, and 30670078), the 973 project (2003CB114202), and the PSA project from MOST and KNAW (2004CB720404).

We thank Xiulian Sun for statistical analysis and Yanfang Zhang for cell culture.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, People's Republic of China. Phone and fax: 86-27-87199353. E-mail: h.wang{at}wh.iov.cn Back

{triangledown} Published ahead of print on 23 July 2008. Back

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/. Back

{ddagger} M. Wang and Y. Tan contributed equally to this work. Back


arrow
REFERENCES
 
    1
  1. Blissard, G. W., and J. R. Wenz. 1992. Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J. Virol. 66:6829-6835.[Abstract/Free Full Text]
    2. 2
  2. Hefferon, K. L., A. G. P. Oomens, S. A. Monsma, C. M. Finnerty, and G. W. Blissard. 1999. Host cell receptor binding by baculovirus GP64 and kinetics of virion entry. Virology 258:455-468.[CrossRef][Medline]
    3. 3
  3. IJkel, W. F. J., M. Westenberg, R. W. Goldbach, G. W. Blissard, J. M. Vlak, and D. Zuidema. 2000. A novel baculovirus envelope fusion protein with a proprotein convertase cleavage site. Virology 275:30-41.[CrossRef][Medline]
    4. 4
  4. King, L. A., and R. D. Possee. 1992. The baculovirus expression system: a laboratory guide. Chapman & Hall, New York, NY.
    5. 5
  5. Long, G., X. Pan, M. Westenberg, and J. M. Vlak. 2006. Functional role of the cytoplasmic tail domain of the major envelope fusion protein of group II baculoviruses. J. Virol. 80:11226-11234.[Abstract/Free Full Text]
    6. 6
  6. Lung, O., M. Westenberg, J. M. Vlak, D. Zuidema, and G. W. Blissard. 2002. Pseudotyping Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV): F proteins from group II NPVs are functionally analogous to AcMNPV GP64. J. Virol. 76:5729-5736.[Abstract/Free Full Text]
    7. 7
  7. Lung, O. Y., M. Cruz-Alvarez, and G. W. Blissard. 2003. Ac23, an envelope fusion protein homolog in the baculovirus Autographa californica multicapsid nucleopolyhedrovirus, is a viral pathogenicity factor. J. Virol. 77:328-339.[CrossRef][Medline]
    8. 8
  8. Oomens, A. G. P., and G. W. Blissard. 1999. Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus. Virology 254:297-314.[CrossRef][Medline]
    9. 9
  9. Pearson, M. N., C. Groten, and G. F. Rohrmann. 2000. Identification of the Lymantria dispar nucleopolyhedrovirus envelope fusion protein provides evidence for a phylogenetic division of the baculoviridae. J. Virol. 74:6126-6131.[Abstract/Free Full Text]
    10. 10
  10. Pearson, M. N., R. L. Russell, and G. F. Rohrmann. 2001. Characterization of a baculovirus-encoded protein that is associated with infected-cell membranes and budded virions. Virology 291:22-31.[CrossRef][Medline]
    11. 11
  11. Pearson, M. N., R. L. Q. Russell, and G. F. Rohrmann. 2002. Functional analysis of a conserved region of the baculovirus envelope fusion protein, LD130. Virology 304:81-88.[CrossRef][Medline]
    12. 12
  12. Wang, M., Y. Tan, F. Yin, F. Deng, J. M. Vlak, Z. Hu, and H. Wang. 2008. The F protein of Helicoverpa armigera single nucleopolyhedrovirus can be substituted functionally with its homologue from Spodoptera exigua multiple nucleopolyhedrovirus. J. Gen. Virol. 89:791-798.[Abstract/Free Full Text]
    13. 13
  13. Westenberg, M., H. Wang, W. F. J. IJkel, R. W. Goldbach, J. M. Vlak, and D. Zuidema. 2002. Furin is involved in baculovirus envelope fusion protein activation. J. Virol. 76:178-184.[Abstract/Free Full Text]
    14. 14
  14. Whitford, M., S. Stewart, J. Kuzio, and P. Faulkner. 1989. Identification and sequence analysis of a gene encoding gp67, an abundant envelope glycoprotein of the baculovirus Autographa californica nuclear polyhedrosis virus. J. Virol. 63:1393-1399.[Abstract/Free Full Text]
    15. 15
  15. Wu, W., T. Lin, L. Pan, M. Yu, Z. Li, Y. Pang, and K. Yang. 2006. Autographa californica multiple nucleopolyhedrovirus nucleocapsid assembly is interrupted upon deletion of the 38K gene. J. Virol. 80:11475-11485.[Abstract/Free Full Text]
    16. 16
  16. Zhou, J., and G. W. Blissard. 2008. Display of heterologous proteins on gp64-null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct. J. Virol. 82:1368-1377.[Abstract/Free Full Text]

Journal of Virology, October 2008, p. 9800-9804, Vol. 82, No. 19
0022-538X/08/$08.00+0     doi:10.1128/JVI.00759-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Yu, I.-L., Bray, D., Lin, Y.-C., Lung, O. (2009). Autographa californica multiple nucleopolyhedrovirus ORF 23 null mutant produces occlusion-derived virions with fewer nucleocapsids. J. Gen. Virol. 90: 1499-1504 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, M.
Right arrow Articles by Wang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, M.
Right arrow Articles by Wang, H.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»